1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Institution opt-in due Oct 9, 2026; LOI due Nov 30, 2026 (1pm ET); full application due Jan 18, 2027 (1pm ET) — final submission date.
Susan G. Komen Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC is sponsored by Susan G. Komen.
This grant supports research focused on the biological underpinnings of Inflammatory Breast Cancer (IBC). Susan G. Komen awards grants to support cutting-edge breast cancer research that will provide the greatest benefit to patients.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official RFP to help you evaluate fit faster.
Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC 2026 Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC supports researchers studying the disease’s biological mechanisms to advance understanding and improve patient care and outcomes.
Cancer Research Grants 2026 Foundation Grants for Biomedical Research Due Dates: October 9, 2026 (Institution opt-in) | November 30, 2026 , by 1 p. m. Eastern Time (LOI) | January 18, 2027 , by 1 p.
m. Eastern Time (Full application) Funding Amounts: Up to $125,000 in combined direct and indirect costs for one year Summary: Supports innovative, hypothesis-driven research into inflammatory breast cancer biology to improve patient care and outcomes. Key Information: Each institution may nominate only one applicant; applicants cannot self-nominate.
Susan G. Komen supports innovative, hypothesis-driven research that advances understanding of the biological mechanisms driving inflammatory breast cancer (IBC), a rare and highly aggressive disease. The program seeks new ideas and areas of investigation with significant potential to improve IBC patient care and outcomes.
It addresses gaps in biological knowledge that hinder the development of IBC-specific biomarkers and targeted therapies. Applicants are strongly encouraged to address IBC onset and development, metastatic dissemination, or monitoring and detection.
Relevant work includes tumor and host microenvironments, genetic factors, epigenetic and proteomic drivers, biological contributors to health disparities, cell migration, therapeutic response, minimal residual disease, prognostication, and theragnostic strategies. Shared research tools, models, datasets, and other resources are also encouraged, particularly when they enable new investigations or inform larger-scale studies.
See the full grant listing
According to the current listing, eligibility includes: Not specified, but generally for researchers and institutions focused on breast cancer research. Confirm the full requirements in the official notice before applying.
Applications for Susan G. Komen Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC are due January 18, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Susan G. Komen Inflammatory Breast Cancer (IBC) Research Grant: Biological Underpinnings of IBC is funded by Susan G. Komen. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.